Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492

Article  PubMed  Google Scholar 

Safaeian M, Sherman ME (2013) From papanicolaou to papillomaviruses: evolving challenges in cervical cancer screening in the era of human papillomavirus vaccination. J Natl Cancer Inst 105:1524–1526. https://doi.org/10.1093/jnci/djt267

Article  CAS  PubMed  PubMed Central  Google Scholar 

Laengsri V, Kerdpin U, Plabplueng C, Treeratanapiboon L, Nuchnoi P (2018) Cervical Cancer markers: epigenetics and microRNAs. Lab Med 49:97–111. https://doi.org/10.1093/labmed/lmx080

Article  PubMed  Google Scholar 

Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, Young N, Forum Group Members, Bethesda 2001 Workshop (2002) The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 287:2114–2119

Article  PubMed  Google Scholar 

Crosbie E, Einstein M et al (2013) Human papillomavirus and cervical cancer. Lancet 382:889–899. https://doi.org/10.1016/S0140-6736(13)60022-7

Article  PubMed  Google Scholar 

Ronco G, Dillner J, Elfström KM, Tunesi S, Snijders PJF, Arbyn M, Kitchener H, Segnan N, Gilham C, Giorgi-Rossi P, Berkhof J, Peto J, Meijer CJLM (2014) Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 383:524–532. https://doi.org/10.1016/S0140-6736(13)62218-7

Article  PubMed  Google Scholar 

Isidean SD, Franco EL (2014) Embracing a new era in cervical cancer screening. Lancet 383:493–494. https://doi.org/10.1016/S0140-6736(13)62028-0

Article  PubMed  Google Scholar 

Arbyn M, Ronco G, Anttila A, Meijer CJLM, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J (2012) Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 30:F88–F99. https://doi.org/10.1016/j.vaccine.2012.06.095

Article  PubMed  Google Scholar 

Tornesello ML, Buonaguro L, Giorgi-Rossi P, Buonaguro FM (2013) Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer. Biomed Res Int 2013:519619–519610. https://doi.org/10.1155/2013/519619

Article  PubMed  PubMed Central  Google Scholar 

Nicolás I, Saco A, Barnadas E, Marimon L, Rakislova N, Fusté P, Rovirosa A, Gaba L, Buñesch L, Gil-Ibañez B, Pahisa J, Díaz-Feijoo B, Torne A, Ordi J, del Pino M (2020) Prognostic implications of genotyping and p16 immunostaining in HPV-positive tumors of the uterine cervix. Mod Pathol 33:128–137. https://doi.org/10.1038/s41379-019-0360-3

Article  CAS  PubMed  Google Scholar 

Galamb Á, Benczik M, Zinner B, Vígh E, Baghy K, Jeney C, Kiss A, Lendvai G, Sobel G (2015) Dysregulation of microRNA expression in human cervical preneoplastic and neoplastic lesions. Pathol Oncol Res Oncol Ogy Res 21:503–508

Article  CAS  Google Scholar 

Pereira PM, Marques JP, Soares AR, Carreto L, Santos MAS (2010) Microrna expression variability in human cervical tissues. PLoS One 5:e11780. https://doi.org/10.1371/journal.pone.0011780

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gocze K, Gombos K et al (2013) Unique microRNA expression profiles in cervical cancer. Anticancer Res 33:2561–2568

CAS  PubMed  Google Scholar 

Gocze K, Gombos K, Kovacs K, Juhasz K, Gocze P, Kiss I (2015) MicroRNA expressions in HPV-induced cervical dysplasia and cancer. Anticancer Res 35:523–530

CAS  PubMed  Google Scholar 

Pedroza-Torres A, Fernández-Retana J, Peralta-Zaragoza O, Jacobo-Herrera N, Cantú de Leon D, Cerna-Cortés JF, Lopez-Camarillo C, Pérez-Plasencia C (2016) A microRNA expression signature for clinical response in locally advanced cervical cancer. Gynecol Oncol 142:557–565. https://doi.org/10.1016/j.ygyno.2016.07.093

Article  CAS  PubMed  Google Scholar 

Liu SS, Chan KKL, Chu DKH, Wei TN, Lau LSK, Ngu SF, Chu MMY, Tse KY, Ip PPC, Ng EKO, Cheung ANY, Ngan HYS (2018) Oncogenic microRNA signature for early diagnosis of cervical intraepithelial neoplasia and cancer. Mol Oncol 12:2009–2022. https://doi.org/10.1002/1878-0261.12383

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pardini B, De Maria D et al (2018) MicroRNAs as markers of progression in cervical cancer: a systematic review. BMC Cancer 18:1–17. https://doi.org/10.1186/s12885-018-4590-4

Article  CAS  Google Scholar 

Kawai S, Fujii T, Kukimoto I, Yamada H, Yamamoto N, Kuroda M, Otani S, Ichikawa R, Nishio E, Torii Y, Iwata A (2018) Identification of miRNAs in cervical mucus as a novel diagnostic marker for cervical neoplasia. Sci Rep 8:1–11. https://doi.org/10.1038/s41598-018-25310-1

Article  CAS  Google Scholar 

Wang S, Chen X (2018) Identification of potential biomarkers in cervical cancer with combined public mRNA and miRNA expression microarray data analysis. Oncol Lett 16:5200–5208. https://doi.org/10.3892/ol.2018.9323

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kocsis A, Takács T, Jeney C, Schaff Z, Koiss R, Járay B, Sobel G, Pap K, Székely I, Ferenci T, Lai HC, Nyíri M, Benczik M (2017) Performance of a new HPV and biomarker assay in the management of hrHPV positive women: subanalysis of the ongoing multicenter TRACE clinical trial (n > 6,000) to evaluate POU4F3 methylation as a potential biomarker of cervical precancer and cancer. Int J Cancer 140:1119–1133. https://doi.org/10.1002/ijc.30534

Article  CAS  PubMed  Google Scholar 

Andersen CL, Jensen JL, Ørntoft TF (2004) Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and Colon Cancer data sets. Cancer Res 64:5245–5250. https://doi.org/10.1158/0008-5472.CAN-04-0496

Article  CAS  PubMed  Google Scholar 

Yang Y, Liu Y, Li G, Li L, Geng P, Song H (2018) MicroRNA-214 suppresses the growth of cervical cancer cells by targeting EZH2. Oncol Lett 16:5679–5686. https://doi.org/10.3892/ol.2018.9363

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen R, Shi YH et al (2018) Systematic prediction of target genes and pathways in cervical cancer from microRNA expression data. Oncol Lett 15:9994–10000. https://doi.org/10.3892/ol.2018.8566

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dweep H, Sticht C, Pandey P, Gretz N (2011) miRWalk--database: prediction of possible miRNA binding sites by “walking” the genes of three genomes. J Biomed Inform 44:839–847. https://doi.org/10.1016/j.jbi.2011.05.002

Article  CAS  PubMed  Google Scholar 

Iorio MV, Croce CM (2012) Causes and consequences of MicroRNA dysregulation. Cancer J (United States) 18:215–222. https://doi.org/10.1097/PPO.0b013e318250c001

Article  CAS  Google Scholar 

Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles G, Clark NR, Ma’ayan A (2013) Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14:128. https://doi.org/10.1186/1471-2105-14-128

Article  PubMed  PubMed Central  Google Scholar 

González-Quintana V, Palma-Berré L et al (2016) MicroRNAs are involved in cervical cancer development, progression, clinical outcome and improvement treatment response (review). Oncol Rep 35:3–12. https://doi.org/10.3892/or.2015.4369

Article  CAS  PubMed  Google Scholar 

Kori M, Arga KY (2018) Potential biomarkers and therapeutic targets in cervical cancer: insights from the meta-analysis of transcriptomics data within network biomedicine perspective. PLoS One 13:1–27. https://doi.org/10.1371/journal.pone.0200717

Article  Google Scholar 

Cheung TH, Man KNM, Yu MY, Yim SF, Siu NSS, Lo KWK, Doran G, Wong RRY, Wang VW, Smith DI, Worley Jr MJ, Berkowitz RS, Chung TKH, Wong YF (2012) Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm. Cell Cycle 11:2876–2884. https://doi.org/10.4161/cc.21278